Diagnostic Testing & Technology Report

February 2010

Genetic Variant Linked to Aggressive Form of Prostate Cancer

Researchers have identified an inherited genetic variant associated with aggressive prostate cancer that could one day be used to help distinguish between aggressive and slow-growing forms of the disease at an early stage.

February 2010 - Table of Contents

DTTR February 2010 (Full PDF Issue)

Genomic Health Revenue Climbs 35% in 2009

Quidel to Acquire Diagnostic Hybrids for $130M

Predictive Biosciences Buys CLIA-Certified Anatomic Pathology Lab

ADA Issues Updated Recommendations for Diabetes Testing

Cepheid Receives FDA Emergency Use Authorization for H1N1 Flu Test

Philips and bioMerieux to Jointly Develop Point-of-Care Tests

Abbott Receives CE Mark for Ovarian Cancer Test

Inside the Diagnostic Industry: Genomic Health Looks to Replicate Its Oncotype DX Across Multiple Cancers, Continents

Seeing Strong Growth in Clinical Applications, Life Technologies Expands Molecular Diagnostics Franchise

Quest Diagnostics Introduces Lab-Developed Test for Colorectal Cancer

Genetic Variant Linked to Aggressive Form of Prostate Cancer

New Payers Sign On to McKesson�s Molecular Dx Criteria Analysis System

Medicare Spending Up, Even as National Health Spending Slows

IVD Stocks Rose 31% in 2009 Led by Inverness, Clinical Data, Affy

G2 Insider (February 2010)

Diagnostic Testing & Technology Report is part of...

Focus Areas	Product Group
G2 Reports Medical Lab Management	Newsletters